Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.
23 results about "Aspartate kinase" patented technology
Filter
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Aspartate kinase (aspartokinase, aspartic kinase) is an enzyme that catalyzes the phosphorylation of the amino acid aspartate. This reaction is the first step in the biosynthesis of three essential amino acids: methionine, lysine, and threonine, known as the "aspartate family". The gene for aspartokinase is present only in microorganisms and plants; it is not present in animals, which must obtain aspartate-family amino acids in their diet.
The invention relates to an Escherichia coli engineering strain for producing 2, 3-pentanediol as well as a construction method and application of the Escherichia coli engineering strain, and the method comprises the following steps: constructing recombinant plasmids pACYC-IlvA *-ThrA * BC for expressing an IlvA * gene of threonine deaminase, a ThrA gene of asparaginic acid kinase I, a Thr B gene of homoserinekinase and a ThrC gene of threonine synthetase; the method comprises the following steps: constructing a recombinant plasmid pRSF-Ilv2C-Aro10 for expressing an Ilv2C gene of acetohydroxy acid synthetase and an Aro10 gene of propiophenonedehydrogenase; and chemically converting the recombinant plasmid pACYC-IlvA *-ThrA * BC and the recombinant plasmid pRSF-Ilv2C-Aro10, and transferring the recombinant plasmid pACYC-IlvA *-ThrA * BC and the recombinant plasmid pRSF-Ilv2C-Aro10 into escherichia coli so as to obtain the escherichia coli engineering strain for producing the 2, 3-pentanediol. According to the escherichia coli engineering strain, the biosynthesis of 1.61 g / L of 2, 3-pentanediol is realized by using L-threonine and 40 g / L of glucose.
The application discloses a recombinant corynebacterium glutamicum with high yield of tetrahydropyrimidine and application thereof, and belongs to the technical field of bioengineering. S301Y By overexpressing aspartate kinase Lyc and aspartate semialdehyde dehydrogenase Asd, the supply of precursor aspartate semialdehyde can be increased. By inserting a repressorprotein BetI binding sequence in the dapA promoter region of dihydropyridinedicarboxylic acid synthetase and overexpressing the repressorprotein BetI, the content of by-product L-lysine in the fermentation liquor can be greatly reduced. By inserting a repressorprotein LmrA binding sequence in the gltA promoter region of citrate synthase and overexpressing the repressor protein LmrA, the imbalance between cell growth and acid fermentation is solved, the supply of precursors oxaloacetate and acetyl CoA is increased, the yield of tetrahydropyrimidine is greatly improved, the yield is as high as 45.5 g / L, and the yield rate is as high as 0.25 g / g glucose.
The invention relates to a recombinant bacterium capable of producing ectoine, L-theanine and collagen III at high yield and application of the recombinant bacterium, and belongs to the technical field of genetic engineering. The recombinant bacteria obtained by introducing plasmids containing ectoine biosynthetase genes and plasmids containing gamma-glutamine synthetase genes and III type collagen genes into corynebacterium glutamicum ATCC 13032 can be used for simultaneously producing ectoine, L-theanine and III type collagen at high yield. Meanwhile, an aspartate kinasegene and an aspartate semialdehyde dehydrogenasegene are connected to a plasmid containing an ectoine biosynthase gene, so that the yield of ectoine is increased. The recombinant bacteria obtained by the transformation can be used for simultaneously synthesizing 25.1 g / L of ectoine, 9.82 g / L of L-theanine and 356 mg / L of III type collagen after being subjected to fermentation culture.